102 related articles for article (PubMed ID: 15569408)
1. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats.
Deng S; Deng PY; Jiang JL; Ye F; Yu J; Yang TL; Deng HD; Li YJ
Acta Pharmacol Sin; 2004 Dec; 25(12):1633-9. PubMed ID: 15569408
[TBL] [Abstract][Full Text] [Related]
2. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
Tan B; Jiang DJ; Huang H; Jia SJ; Jiang JL; Hu CP; Li YJ
Vascul Pharmacol; 2007 May; 46(5):338-45. PubMed ID: 17293168
[TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
Jiang JL; Jiang DJ; Tang YH; Li NS; Deng HW; Li YJ
Acta Pharmacol Sin; 2004 Jul; 25(7):893-901. PubMed ID: 15210062
[TBL] [Abstract][Full Text] [Related]
4. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Jiang JL; Li Ns NS; Li YJ; Deng HW
Br J Pharmacol; 2002 Mar; 135(5):1175-82. PubMed ID: 11877324
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
Tang WJ; Hu CP; Chen MF; Deng PY; Li YJ
Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942
[TBL] [Abstract][Full Text] [Related]
6. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Wang S; Jiang JL; Hu CP; Zhang XJ; Yang DL; Li YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837
[TBL] [Abstract][Full Text] [Related]
7. 17beta-estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Dai Z; Zhu HQ; Jiang DJ; Jiang JL; Deng HW; Li YJ
Int J Cardiol; 2004 Aug; 96(2):223-7. PubMed ID: 15262037
[TBL] [Abstract][Full Text] [Related]
8. Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
Yang TL; Chen MF; Luo BL; Yu J; Jiang JL; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):79-83. PubMed ID: 15316718
[TBL] [Abstract][Full Text] [Related]
9. Dimethylarginine dimethylaminohydrolase inhibition and asymmetric dimethylarginine accumulation contribute to endothelial dysfunction in rats exposed to glycosylated protein: effects of aminoguanidine.
Yin QF; Fu SH; He P; Xiong Y
Atherosclerosis; 2007 Jan; 190(1):53-61. PubMed ID: 16533509
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine.
Jiang DJ; Jiang JL; Tan GS; Du YH; Xu KP; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):600-6. PubMed ID: 12750878
[TBL] [Abstract][Full Text] [Related]
11. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors.
Jiang DJ; Hu GY; Jiang JL; Xiang HL; Deng HW; Li YJ
Bioorg Med Chem; 2003 Nov; 11(23):5171-7. PubMed ID: 14604680
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of lovastatin on vascular endothelium injured by low density lipoprotein.
Ma FX; Liu LY; Xiong XM
Acta Pharmacol Sin; 2003 Oct; 24(10):1027-32. PubMed ID: 14531947
[TBL] [Abstract][Full Text] [Related]
13. A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats.
Fu YF; Xiong Y; Guo Z
Eur J Pharmacol; 2005 Jan; 508(1-3):167-75. PubMed ID: 15680268
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.
Lu CW; Lin Y; Lei YP; Wang L; He ZM; Xiong Y
PLoS One; 2017; 12(7):e0179908. PubMed ID: 28715444
[TBL] [Abstract][Full Text] [Related]
15. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
Lin KY; Ito A; Asagami T; Tsao PS; Adimoolam S; Kimoto M; Tsuji H; Reaven GM; Cooke JP
Circulation; 2002 Aug; 106(8):987-92. PubMed ID: 12186805
[TBL] [Abstract][Full Text] [Related]
16. Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Jiang DJ; Jiang JL; Zhu HQ; Tan GS; Liu SQ; Xu KP; Li YJ
J Ethnopharmacol; 2004 Aug; 93(2-3):295-306. PubMed ID: 15234768
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats.
Xiong Y; Yuan LW; Deng HW; Li YJ; Chen BM
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):842-7. PubMed ID: 11553026
[TBL] [Abstract][Full Text] [Related]
18. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
Yang TL; Chen MF; Luo BL; Xie QY; Jiang JL; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
